Dr. 고광철
Dr. Ko Kwang Chul
학력
1999.02 서울대학교 내과학 박사
1995.02 서울대학교 내과학 석사
1985.02 서울대학교 의학과 학사
경력
2017.04 ~현재 삼성서울병원 미래병원 추진단장
2007.09 ~현재 성균관대학교 삼성서울병원 교수
1994.03 ~현재 삼성서울병원 전문의
2012.03 ~ 2017.03 삼성서울병원 기획실장
2010.04 ~ 2012.02 삼성서울병원 적정진료운영실 실장(QA담당)
2008.08 ~ 2010.03 삼성서울병원 적정진료운영실 실차장(QA담당)
2001.09 ~ 2007.08 성균관대학교 삼성서울병원 부교수
1997.03 ~ 2001.08 성균관대학교 삼성서울병원 조교수
2000.03 ~ 2001.02 Yale Liver Center 연수 (1년)
1992.05 ~ 1994.02 서울대학교 병원 전임의
1989.04 ~ 1992.04 군복무
1986.05 ~ 1989.02 서울대학교 병원 레지던트
학회
2011.11 ~ 현재 현재 대한간학회 평의원
2013.10 ~ 2014.01 대한간학회 간질환 백서 자문위원
2012.03 ~ 2013.11 대한간학회 학술연구지원사업 운영위원
2007.12 ~ 2009.12 대한간학회 학술위원장
2007.09 ~ 2008.06 간암연구회 총무
2006.01 ~ 2008.03 아태간학회 2008 조직위원회 전산위원장
논문
J GASTROEN HEPATOL 2019 10.1111/jgh.14750
Hepatitis B virus DNA levels and overall survival in hepatitis B-related hepatocellular carcinoma patients with low-level viremia
Kim1, TS; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
PLoS One 2019 10.1371/journal.pone.0213547
Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
Kim1, J; Sinn, DH; Choi, MS; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW
PLoS One 2019 10.1371/journal.pone.0210730
Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients
Sinn1, DH; Choi, GS; Park, HC; Kim, JM; Kim, H; Song, KD; Kang, TW; Lee, MW; Rhim, H; Hyun, D; Cho, SK; Shin, SW; Jeong, WK; Kim, SH; Il Yu, J; Ha, SY; Lee, SJ; Lim, HY; Kim, K; Ahn, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Joh, JW; Lim, HK; Paik, SW
ANN SURG TREAT RES 2019 10.4174/astr.2019.96.1.14
Impact of technical innovation on surgical outcome of laparoscopic major liver resection: 10 years' experience at a large-volume center
Cho1, W; Kwon, CHD; Choi, JY; Lee, SH; Kim, JM; Choi, GS; Joh, JW; Kim, SJ; Kim, GS; Koh, KC
EUR J GASTROEN HEPAT 2018 10.1097/MEG.0000000000001226
Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
Song1, BG; Sinn, DH; Chi, S; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
LIVER INT 2018 10.1111/liv.13732
Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy
Bae1, J; Sinn, DH; Kang, W; Gwak, GY; Choi, MS; Paik, YH; Lee, JH; Koh, KC; Paik, SW
SCAND J GASTROENTERO 2018 10.1080/00365521.2018.1458895
Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?
Kim1, KM; Kim, J; Sinn, DH; Kim, HS; Kim, K; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
DIGEST DIS SCI 2018 10.1007/s10620-018-4934-6
Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization
Kim1, JH; Sinn, DH; Lee, JH; Hyun, D; Cho, SK; Shin, SW; Chang, Y; Kim, YJ; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Choi, MS
LIVER INT 2018 10.1111/liv.13489
Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia
Paik1, N; Sinn, DH; Lee, JH; Oh, IS; Kim, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
DIGEST DIS SCI 2017 10.1007/s10620-017-4775-8
Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation
Oh1, IS; Sinn, DH; Kang, TW; Lee, MW; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
WORLD J SURG 2017 10.1007/s00268-017-4105-5
Short-Term Outcomes of Totally Laparoscopic Central Hepatectomy and Right Anterior Sectionectomy for Centrally Located Tumors: A Case-Matched Study with Propensity Score Matching
Cho1, CW; Rhu, J; Kwon, CHD; Choi, GS; Kim, JM; Joh, JW; Koh, KC; Kim, GS
ONCOTARGET 2017 10.18632/oncotarget.17072
Combination treatment with transarterial chemoembolization, radiotherapy, and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumor thrombosis: Final results of a prospective phase II trial
Yu1, JI; Park, HC; Jung, SH; Choi, C; Shin, SW; Cho, SK; Sinn, DH; Paik, YH; Gwak, GY; Choi, MS; Lee, JH; Koh, KC; Yoo, BC; Sahinbas, H; Paik, SW
HEPATOLOGY 2017 10.1002/hep.28916
Low-Level Viremia and the Increased Risk of Hepatocellular Carcinoma in Patients Receiving Entecavir Treatment
Kim1, JH; Sinn, DH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
GUT LIVER 2017 10.5009/gnl16403
A Novel Model for Predicting Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase Levels
Sinn1, DH; Lee, JH; Kim, K; Ahn, JH; Lee, JH; Kim, JH; Lee, DH; Yoon, JH; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
KOREAN JOURNAL OF INTERNAL MEDICINE 2017 10.3904/kjim.2016.096
Long-term real-world entecavir therapy in treatment-naive hepatitis B patients: base-line hepatitis B virus DNA and hepatitis B surface antigen levels predict virologic response
Cho1, JY; Sohn, W; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Koh, KC; Paik, SW; Yoo, BC; Lee, JH
J Gastroenterol Hepatol. 2017 May;32(5):1064-1070. doi: 10.1111/jgh.13637.
Proton pump inhibitors do not increase the risk for recurrent spontaneous bacterial peritonitis in patients with cirrhosis
Kim JH11, Lim KS1, Min YW1, Lee H1, Min BH1, Rhee PL1, Kim JJ1, Koh KC1, Paik SW1.
J Gastroenterol Hepatol. 2017 May;32(5):1100-1106. doi: 10.1111/jgh.13647.
Insulin resistance and the risk of hepatocellular carcinoma in chronic hepatitis B patients
Kim JH11, Sinn DH1, Gwak GY1, Kang W1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
Medicine (Baltimore). 2016 Dec;95(51):e5666. doi: 10.1097/MD.0000000000005666.
The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma
Kim JH11, Min YW, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.
Dig Dis Sci. 2016 Nov;61(11):3354-3362. Epub 2016 Jul 19.
Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma
Kim JH11, Sinn DH2, Kim K3, Kang W1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
Gut Liver. 2016 Nov 15;10(6):939-947. doi: 10.5009/gnl15527.
Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
Kim JH11, Sinn DH1, Kim K2, Kim H2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
Liver Int. 2016 Oct;36(10):1490-7. doi: 10.1111/liv.13107. Epub 2016 Mar 24.
The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
Kim KM11, Sinn DH2, Jung SH3, Gwak GY2, Paik YH2, Choi MS2, Lee JH2, Koh KC2, Paik SW4.
Gut Liver. 2016 Sep 15;10(5):796-802. doi: 10.5009/gnl15368.
Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index
Lee K11, Sinn DH1, Gwak GY1, Cho HC2, Jung SH3, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
Medicine (Baltimore). 2016 Aug;95(35):e4735. doi: 10.1097/MD.0000000000004735.
Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria: liver transplantation versus locoregional therapy: A retrospective cohort study
Kim JH11, Sinn DH, Gwak GY, Choi GS, Kim JM, Kwon CH, Joh JW, Kim KY, Kim K, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW.
Cardiovasc Intervent Radiol. 2016 Jul;39(7):1015-22. doi: 10.1007/s00270-016-1314-5. Epub 2016 Mar 14.
Treatment of Small Hepatocellular Carcinoma (<= 2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation
Hyun D11, Cho SK2, Shin SW1, Rhim H1, Koh KC3, Paik SW3.
Oncotarget. 2016 Jul 26;7(30):47794-47807. doi: 10.18632/oncotarget.10026.
Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma
Sohn W11,2, Kang TW3, Choi SK4, Jung SH4, Lee MW3, Lim HK3,5, Cho JY1,6, Shim SG7, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Rhim H3, Paik YH1,5.
Int J Hyperthermia. 2016 May;32(3):331-8. doi: 10.3109/02656736.2016.1144895. Epub 2016 Feb 25.
Combination treatment of trans-arterial chemo-embolisation, radiotherapy and hyperthermia (CERT) for hepatocellular carcinoma with portal vein tumour thrombosis: Interim analysis of prospective phase II trial
Yu JI11, Park HC1,2, Oh D1, Noh JM1, Jung SH1, Kim HY1, Shin SW3, Cho SK3, Sinn DH4, Paik YH4, Gwak GY4, Choi MS4, Lee JH4, Koh KC4, Paik SW4, Yoo BC5.
World J Gastroenterol. 2016 Apr 14;22(14):3785-92. doi: 10.3748/wjg.v22.i14.3785.
Characteristics and outcomes of chronic liver disease patients with acute deteriorated liver function by severity of underlying liver disease
Hong YS11, Sinn DH1, Gwak GY1, Cho J1, Kang D1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
Gut Liver. 2016 Mar;10(2):295-302. doi: 10.5009/gnl15155.
Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease
Ahn JM11, Paik YH1, Min SY1, Cho JY1, Sohn W1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
Dig Dis Sci. 2015 Dec;60(12):3794-800. doi: 10.1007/s10620-015-3812-8. Epub 2015 Jul 28.
Stopping Preemptive Antiviral Therapy for Hepatitis B Virus Can Be Considered for Patients with Favorable Predictors
Kim HJ11, Sinn DH2, Kim NJ1, Kim JH1, Kim E1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
PLoS One. 2015 Dec 22;10(12):e0144777. doi: 10.1371/journal.pone.0144777. eCollection 2015.
Prediction of Clinical Outcomes in Hepatitis B E Antigen Negative Chronic Hepatitis B Patients with Elevated Hepatitis B Virus DNA Levels
Ahn JM11,2, Sinn DH1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1.
J Korean Med Sci. 2015 Nov;30(11):1618-24. doi: 10.3346/jkms.2015.30.11.1618. Epub 2015 Oct 16.
Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels
Lee J11, Sinn DH1, Kim JH1, Gwak GY1, Kim HS2, Jung SH2, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.
Hepatology. 2015 Sep;62(3):694-701. doi: 10.1002/hep.27889. Epub 2015 Jul 3.
Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load
Sinn DH11, Lee J1, Goo J2, Kim K2, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Yoo BC1, Paik SW1.
J Viral Hepat. 2015 Jun;22(6):539-50. doi: 10.1111/jvh.12356. Epub 2014 Nov 7.
Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load
Sohn W11, Paik YH, Cho JY, Ahn JM, Choi GS, Kim JM, Kwon CH, Joh JW, Sinn DH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
J Hepatol. 2015 May;62(5):1112-21. doi: 10.1016/j.jhep.2014.12.009. Epub 2014 Dec 13.
Sorafenib therapy for hepatocellular carcinoma with extrahepatic spread: Treatment outcome and prognostic factors
Sohn W11, Paik YH2, Cho JY1, Lim HY1, Ahn JM1, Sinn DH1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
PLoS One. 2015 Apr 29;10(4):e0124434. doi: 10.1371/journal.pone.0124434. eCollection 2015.
Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread
Sinn DH11, Cho JY1, Gwak GY1, Paik YH1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
Hepatogastroenterology. 2015 Mar-Apr;62(138):286-90.
Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses
Huang CS1, Yang SH, Lin CC, Lan YT, Chang SC, Wang HS, Chen WS, Lin TC, Lin JK, Jiang JK.
Digestion. 2015;91(2):150-7. doi: 10.1159/000369789. Epub 2015 Feb 11.
Association between Serum Osteocalcin Levels and Non-Alcoholic Fatty Liver Disease in Women
Sinn DH11, Gwak GY, Rhee SY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, Paik SW.
Korean J Intern Med. 2015 Jan;30(1):32-41. doi: 10.3904/kjim.2015.30.1.32. Epub 2014 Dec 30.
Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients
Kim HJ11, Cho JY1, Kim YJ1, Gwak GY1, Paik YH1, Choi MS1, Koh KC1, Paik SW1, Yoo BC1, Lee JH1.
Gut. 2014 Dec;63(12):1943-50. doi: 10.1136/gutjnl-2013-306409. Epub 2014 Mar 10.
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
Cho JY11, Paik YH1, Sohn W1, Cho HC2, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
Hepatogastroenterology. 2014 Sep;61(134):1704-11.
Hepatitis B Virus Reactivation During Anti-Cancer Chemotherapy in Patients with Past Hepatitis B Virus Infection
Kim E1, Yune S, Ha JM, Lee WJ, Hwang JW, Paik YH, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
Aliment Pharmacol Ther. 2014 Sep;40(6):695-704. doi: 10.1111/apt.12875. Epub 2014 Jul 30.
Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study
Min YW11, Lim KS, Min BH, Gwak GY, Paik YH, Choi MS, Lee JH, Kim JJ, Koh KC, Paik SW, Yoo BC, Rhee PL.
Gut Liver. 2014 Sep;8(5):543-51. doi: 10.5009/gnl13356. Epub 2014 Jul 25.
Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors
Sohn W11, Choi MS1, Cho JY1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
Dig Liver Dis. 2014 Sep;46(9):813-7. doi: 10.1016/j.dld.2014.05.003. Epub 2014 Jun 2.
A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma
Shin JU11, Kim KM2, Shin SW3, Min SY4, Park SU4, Sinn DH4, Gwak GY4, Choi MS4, Lee JH4, Paik SW4, Yoo BC4, Koh KC5.
J Korean Med Sci. 2014 Aug;29(8):1113-9. doi: 10.3346/jkms.2014.29.8.1113. Epub 2014 Jul 30.
Relationship of Liver Stiffness and Controlled Attenuation Parameter Measured by Transient Elastography with Diabetes Mellitus in Patients with Chronic Liver Disease
Ahn JM11, Paik YH1, Kim SH1, Lee JH1, Cho JY1, Sohn W1, Gwak GY1, Choi MS1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
Ann Surg Oncol. 2014 Jul;21(7):2429-35. doi: 10.1245/s10434-014-3621-x. Epub 2014 Mar 12.
HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma
Sohn W11, Paik YH, Kim JM, Kwon CH, Joh JW, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
Atherosclerosis. 2014 Jun;234(2):270-5. doi: 10.1016/j.atherosclerosis.2014.03.001. Epub 2014 Mar 21.
Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease
Sinn DH11, Gwak GY2, Cho J3, Son HJ4, Paik YH5, Choi MS5, Lee JH5, Koh KC5, Paik SW5, Yoo BC5.
J Gastroenterol Hepatol. 2014 May;29(5):1043-8. doi: 10.1111/jgh.12504.
Long- term survival after surgical resection for huge hepatocellular carcinoma: Comparison with transarterial chemoembolization after propensity score matching
Min YW11, Lee JH, Gwak GY, Paik YH, Lee JH, Rhee PL, Koh KC, Paik SW, Yoo BC, Choi MS.
Liver Int. 2014 May;34(5):795-801. doi: 10.1111/liv.12445. Epub 2014 Jan 12.
The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma
Cho JY11, Paik YH, Park HC, Yu JI, Sohn W, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
Scand J Gastroenterol. 2014 Mar;49(3):373-80. doi: 10.3109/00365521.2013.871745. Epub 2013 Dec 19.
Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation
Sohn W11, Paik YH, Lee MW, Rhim H, Lim HK, Cho JY, Gwak GY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.
Gut Liver. 2014 Jan;8(1):58-63. doi: 10.5009/gnl.2014.8.1.58. Epub 2013 Nov 21.
Clinical Features, Image Findings, and Prognosis of Inflammatory Pseudotumor of the Liver: A Multicenter Experience of 45 Cases
Park JY11, Choi MS1, Lim YS2, Park JW2, Kim SU3, Min YW1, Gwak GY1, Paik YH1, Lee JH1, Koh KC1, Paik SW1, Yoo BC1.
Antivir Ther. 2013;18(6):765-73. doi: 10.3851/IMP2664. Epub 2013 Jul 31.
Efficacy and safety of pegylated interferon-alpha 2a in patients with lamivudine-resistant HBeAg-positive chronic hepatitis B
Suh DJ11, Lee HC, Byun KS, Cho M, Kweon YO, Tak WY, Chon CY, Koh KC, Lee YS.
Cancer. 2013 Jan 1;119(1):136-42. doi: 10.1002/cncr.27705. Epub 2012 Jun 26.
Genetic predisposition of hand-foot skin reaction after sorafenib therapy in patients with hepatocellular carcinoma
Lee JH11, Chung YH, Kim JA, Shim JH, Lee D, Lee HC, Shin ES, Yoon JH, Kim BI, Bae SH, Koh KC, Park NH.
Gut Liver. 2010 Dec;4(4):530-6. doi: 10.5009/gnl.2010.4.4.530. Epub 2010 Dec 17.
A Low Viral Load Predicts a Higher Initial Virologic Response to Adefovir in Patients with Lamivudine-Resistant Chronic Hepatitis B
Shin SR11, Koh KC, Gwak GY, Choi MS, Lee JH, Paik SW, Yoo BC.
Clin Exp Rheumatol. 2007 Nov-Dec;25(6):888-9.
Fatal hepatic failure associated with hepatitis B virus reactivation in a hepatitis B surface antigen-negative patient with rheumatoid arthritis receiving low dose methotrexate
Gwak GY11, Koh KC, Kim HY.
Am J Surg. 2006 Jul;192(1):29-33.
Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma
Park JH11, Koh KC, Choi MS, Lee JH, Yoo BC, Paik SW, Rhee JC, Joh JW.
J Vasc Surg. 2006 Jan;43(1):101-8.
Primary Budd-Chiari syndrome: Outcome of endovascular management for suprahepatic venous obstruction
Lee BB11, Villavicencio L, Kim YW, Do YS, Koh KC, Lim HK, Lim JH, Ahn KW.
Hepatogastroenterology. 2005 Nov-Dec;52(66):1832-5.
The relationship between apolipoprotein e polymorphism, lipoprotein (a) and fatty liver disease
Yang MH11, Son HJ, Sung JD, Choi YH, Koh KC, Yoo BC, Paik SW.
Am J Surg. 2005 Jan;189(1):120-5.
Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma
Koh KC11, Lee H, Choi MS, Lee JH, Paik SW, Yoo BC, Rhee JC, Cho JW, Park CK, Kim HJ.
Hepatogastroenterology. 2003 Jan-Feb;50(49):170-3.
TT virus infection in patients on maintenance hemodialysis in Korea
Choi MS11, Lee JH, Koh KC, Lee JH, Paik SW, Rhee PL, Rhee JC, Choi KW, Huh WS, Oh HY.
AJR Am J Roentgenol. 2000 Sep;175(3):693-8.
Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic livers: Accuracy of helical CT in transplant patients
Lim JH11, Kim CK, Lee WJ, Park CK, Koh KC, Paik SW, Joh JW.
동병원 동일과 LIST
간암,간경화,급성간염,만성간염
월요일오후
화요일오전
화요일오후
목요일오후
금요일오전
위염,십이지장궤양,위궤양,위장질환,기능성소화불량
간암,간경화,급성간염,만성간염,지방간,간질환
월요일오전
화요일오전
화요일오후
수요일오전
목요일오후
간암,간경화,급성간염,만성간염,지방간,간질환
월요일오후
화요일오전
화요일오후
목요일오후
금요일오전
췌장암,담낭암,담도암,췌장염,췌장의양성종양 담석증
암,치료내시경,위선종,식도암,위의양성종양,소화불량
염증성장질환,장결핵,대장암,크론병,궤양성대장염
대장암,대장용종,혈변,유전성대장암,염증성장질환
대장암,대장용종,소장질환,염증성장질환,대장협착
간암,간경화,급성간염,만성간염,지방간,간이식
월요일오전 월요일오후
수요일오후
금요일오후
토요일오전
타병원 동일과 LIST
서울아산병원
궤양성대장염,염증성장질환,크론병,임상연구클리닉
비에비스나무병원
소화불량,위염,위암,역류성식도염,과민성대장증후군
순천향대학교 부천병원
췌장질환,담도질환,담낭질환,소화기질환
서울대학교병원
만성간염,간섬유화,간경변,간세포암종,급성간부전
부산대학교병원
위암,식도암,상부위장관질환,위장관운동질환
순천향대학교 서울병원
췌담도치료내시경,담석증,췌장염,췌담도암,담도암
서울대학교병원
위장질환,대장질환,위암,대장암,식도암
강남세브란스병원
간염,항바이러스치료,지방간,알코올성간질환
분당서울대학교병원
급성간질환,만성간질환,간경변,간암
강북삼성병원
염증성장질환,대장암,소장질환,대장질환
강남세브란스병원
식도암,위선종,위암,대장암,위식도역류질환
신촌세브란스병원
식도암,위암,내시경치료술,역류,소화관운동질환
한양대학교병원
역류성식도염,기능성소화불량증,과민성장증후군
가톨릭대학교 성빈센트병원
염증성장질환,치료내시경,위장질환,대장질환
분당서울대학교병원
위암,위염,위궤양,장염,대장암
충남대학교병원
식도암,위암,대장암,역류성식도염,위궤양
신촌세브란스병원
췌장암,담도암,신경내분비종양,항암약물치료
순천향대학교 서울병원
식도종양,위장관종양,위장관기능장애,운동질환
고려대학교 안암병원
위장관양성질환,식도암,위암,대장암
고려대학교 안암병원
위장관질환,위암,대장암,염증성장질환
고려대학교 안암병원
간암,간질환,간염,간경변증,간경화
가톨릭대학교 서울성모병원
간염,간암,간이식,지방성간질환,난치성간질환
신촌세브란스병원
췌장암,담도암,신경내분비종양,항암치료,치료내시경
신촌세브란스병원
염증성장질환,대장암,소화기질환
부산대학교병원
위장관질환,대장질환,염증성장질환,베체트병,장결핵
고신대학교복음병원
췌장질환,담도계질환,담석증,담낭염,담관염,췌장암
가톨릭대학교 서울성모병원
위암,위식도역류질환,식도암
가톨릭대학교 서울성모병원
간이식,간암,간염,담도암
가톨릭대학교 서울성모병원
담관질환,담도암,췌장질환,치료내시경
가톨릭대학교 서울성모병원
대장암용종,크론병,장베체트병,궤양성대장염
가톨릭대학교 서울성모병원
소화기종양치료내시경,위암
가톨릭대학교 서울성모병원
위암,위염,소화성궤양,내시경초음파
가톨릭대학교 서울성모병원
간염,간암,간경변,간이식
이대목동병원
위암,헬리코박터감염,위식도역류질환
서울아산병원
간질환,간암,간염,간경변,지방간클리닉
서울아산병원
위질환,식도질환,십이지장질환,치료내시경
서울아산병원
대장질환,소장질환,변비,과민성장증후군
서울아산병원
대장질환,소장질환,치료대장내시경,염증성장질환
서울아산병원
위질환,식도질환,십이지장질환,위암,식도암
서울아산병원
조기위암,조기식도암,내시경치료,위궤양,십이지장궤양
서울아산병원
조기대장암,조기유암종,내시경치료,대장암,소장질환
서울아산병원
궤양성대장염,크론병,베체트장염,장결핵,염증성장질환
고려대학교 안암병원
췌담도질환,담석,담낭염,담도암,췌장염
고려대학교 안암병원
췌담도질환,담석,담낭염,담도암,췌장염
강남세브란스병원
췌장담도질환,췌담도암,췌담도양성질환
강남세브란스병원
치료내시경,위암,식도암,대장암,위식도역류질환
서울아산병원
위질환,식도질환,십이지장질환,위암,식도암
서울아산병원
위장관질환,위질환,식도질환,십이지장질환
서울아산병원
식도운동질환,기능성위장관질환,외국인진료
서울아산병원
위질환,식도질환,십이지장질환,치료내시경
강동경희대학교병원
대장내시경,대장암,대장용종,위암,식도암
용인세브란스병원
소화기암,치료내시경,췌장담도계질환
동국대학교 일산병원
간질환,지방간,간염,간경변,간암,소화기일반
동국대학교 일산병원
소화기질환, 소화기암,위장관운동질환,염증성장질환
순천향대학교 부천병원
위,식도간질환,대장항문병
순천향대학교 부천병원
위,식도대장항문병,소화기
순천향대학교 부천병원
식도위질환치료내시경,기능성위장질환
보라매서울대학교병원
역류성식도염,위염,위궤양,대장질환소화기암
보라매서울대학교병원
식도염,위염,위궤양,소화불량,소화기암
보라매서울대학교병원
급성만성간질환,간경변,간암,위염,위궤양
인제대학교 서울백병원
위염,위암,소화불량,식도염
|
|